Table 3 Eczema Area and Severity Index (EASI) scores in patients with conjunctivitis.

From: Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae

Patient

EASI pre-treatment

EASI at week 16

EASI 50 achieved

EASI 75 achieved

1

9.2

1

Yes

Yes

2

12.5

1

Yes

Yes

3

4.9

2.5

No

No

4

16.8

2.4

Yes

Yes

5

51.4

8.6

Yes

Yes

6

17

1

Yes

Yes

7

26

12.9

Yes

No

8

24

7.5

Yes

No

9

5

2

Yes

No

  1. EASI 50 at least 50% reduction in Eczema Area and Severity Index score at 16 weeks, EASI 75 at least 75% reduction in Eczema Area and Severity Index score at 16 weeks.